Teleflex Inc (TFX): Utang-utang marang kapitalisasi buku

Logo grafis Teleflex Inc. (TFX)

This TFX chart on the GURU.Markets platform illustrates the price action of the company producing diagnostic and therapy equipment. The efficiency of catheter assembly and surgery plants ensures the 0.92 metric. The business relies on the exclusivity of resuscitation tools, which guarantees profit stability. Growth prospects are based on the expansion of the vascular segment and an aging population, which stimulates demand for outpatient surgeries.

Teleflex Incorporated - Utang-utang marang kapitalisasi buku TFX (periode 04.07.2022 - 26.10.2026)

Rincian metrik lan analitis perusahaan Teleflex Inc. (TFX)

- rega lan prakiraan konsensus rega:
Rega saham Teleflex Incorporated|TFX - Target median analis
- data kapitalisasi pasar:
Kapitalisasi pasar Teleflex Corp|TFX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Nilai Buku saben Saham Teleflex|TFX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku teleflex.com|TFX - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Teleflex Incorporated|TFX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Teleflex Inc|TFX - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Teleflex Corp
Ringkesan analitik perusahaan:TFX - Teleflex Incorporated
Barang utama Teleflex Inc.

Amid intense price competition with medical conglomerates for clinic contracts, the stability of Teleflex Incorporated (TFX) depends on the balance between borrowed funds and equity. This indicator measures the share of total debt within the company's book value structure, reflecting the degree of financial leverage. By analyzing the ratio of debt to the company's book capitalization, an investor can assess the risk of over-leverage and the issuer's potential vulnerability to market volatility.

Karo sapa Teleflex Incorporated saingan

Utang-utang marang kapitalisasi buku ISRG|Utang-utang marang aset resik danaher.com DHR|BDX: Utang-utang marang kapitalisasi buku|STE - Utang marang nilai buku|WST: Utang-utang marang kapitalisasi buku|BAX (Baxter Healthcare) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Masimo Corporation|Rasio utang marang kapitalisasi buku stevanatogroup.com (STVN)|Merit Medical (MMSI) - Utang marang nilai buku|Rasio utang marang aset resik Envista Holdings Corporation (NVST)|Utang-utang marang kapitalisasi buku ICUI|Sirona Dental Systems - Utang-utang marang aset resik|LeMaitre Vascular, Inc. (LMAT) - Rasio utang marang kapitalisasi buku|ATRC: Rasio utang marang nilai buku|STAAR Surgical - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ChromaDex Corporation|ZimVie Dental (ZIMV) - Utang marang nilai buku|Utang marang modal buku ANGO|Cerus Corporation (CERS) - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik teknova.com TKNO|Utang marang nilai buku MGRM (Monogram Orthopedics)|Sharps Technology Inc - Utang-utang marang kapitalisasi buku|INFU: Rasio utang marang kapitalisasi buku|UTMD - Utang marang nilai buku|Utang-utang marang kapitalisasi buku KRMD|NYXH (nyxoah.com) - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Microbot Medical (MBOT)|Rasio utang marang nilai buku Pro-Dex Inc (PDEX)|Utang marang nilai buku Zentek Limited|Utang marang modal buku ELUT (Elutia Corporation)|Rasio utang marang kapitalisasi buku MLSS|NXGL - Utang-utang marang aset resik|Utang marang nilai buku Retractable Tech RVP|HBIO - Utang marang modal buku|Utang-utang marang kapitalisasi buku FEMY|MHUA (Meihua Medical Technologies Co., Ltd.) - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Predictive Oncology Inc|Rasio utang marang kapitalisasi buku Callan JMB Corp|Atrion - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku NeuroMetrix Inc (NURO)